Overview
Lobbying Costs
300,000€
Financial year: Jan 2021 - Dec 2021
Lobbyists (Full time equivalent)
3.75 Fte (5)
Lobbyists with EP accreditation
4
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
CONCILIUS AG
EU Transparency Register
695550548409-69 First registered on 16 Dec 2022
Goals / Remit
CONCILIUS advises companies, associations and other social actors at the interfaces with politics and administration in Germany and with the institutions of the European Union. With offices not only in Berlin and Brussels, but also in Munich, Stuttgart, Dusseldorf and Hamburg, we are able to address the special requirements of the federal political system in the best possible way. In addition to our services at EU, federal and state level, our clients value our expertise in supporting projects at the municipal level. Our consultants have excellent references and decades of experience in successfully dealing with regulatory issues in almost every industry sector. We emphasise a comprehensible, analysis-based and content- and target-oriented approach.
CONCILIUS was founded in 2003 and is still managed by its owners.Main EU files targeted
Revision of the general pharmaceuticals legislation; Revision of the EU OMP Regulation; Cross-Border Healthcare Directive; European Health Data Space; Clinical Trials Regulation (CTR); EU-HTA Regulation; Pharmaceutical Strategy for Europe; Digital Services Act; Digital Markets Act; Data Act; Implementation of Global Minimum Corporate Taxation; Secure Space-based Connectivity Regulation; General Product Safety Regulation; Artificial Intelligence Act; Plattform Work Directive; Standardisation Strategy; Standardisation Regulation; Machinery Regulation; Construction Products Regulation; Beating Cancer Plan; EMA Fees regulation; ‘Healthier Together’ Non-Communicable Diseases plan; Intellectual Property Rights and Incentives; Anti-Microbial Resistance; Industrial Strategy; Pharmaceutical Strategy; International Trade; International Health Regulations
Address
Head Office
Hermann-Sack-Strasse 3
Munich 80331
GERMANYEU Office
CONCILIUS Europe SRL Avenue de Cortenbergh 52
Brussels 1000
BELGIUMWebsite
-
People
Total lobbyists declared
5
Employment time Lobbyists 100% 3 50% 1 25% 1 Lobbyists (Full time equivalent)
3.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
4 accreditations were / are live (in bold) for the selected state of 17 Mar 2023
Name Start date End Date Timothy MORRIS 22 Feb 2024 21 Feb 2025 Sophie LOEW 22 Feb 2024 21 Feb 2025 Marta DAKIC 22 Feb 2024 21 Feb 2025 Arianna COLAIUTA 22 Feb 2024 21 Feb 2025 Lennart DROEGE 22 Feb 2024 21 Feb 2025 Mr Timothy MORRIS 22 Feb 2024 15 Apr 2024 Ms Sophie LOEW 22 Feb 2024 15 Apr 2024 Ms Marta DAKIC 22 Feb 2024 15 Apr 2024 Ms Arianna COLAIUTA 22 Feb 2024 15 Apr 2024 Mr Lennart DROEGE 22 Feb 2024 15 Apr 2024 Ms Sophie LOEW 30 Mar 2023 22 Feb 2024 Mr Lennart DROEGE 23 Feb 2023 22 Feb 2024 Ms Marta DAKIC 21 Feb 2023 21 Feb 2024 Ms Arianna COLAIUTA 21 Feb 2023 21 Feb 2024 Ms Mirjam FRAKULLA 21 Feb 2023 21 Feb 2024 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Professional consultancies
-
Networking
Affiliation
American Chamber of Commerce in Germany e.V.
de'ge'pol - Deutsche Gesellschaft für Politikberatung e.V.
Deutsche Gesellschaft für Auswärtige Politik e. V.
DEUTSCHE GESELLSCHAFT FÜR WEHRTECHNIK e. V. (DWT)
Förderkreis Deutsches Heer e.V.
Forum Luft- und Raumfahrt e.V.
Wirtschaftsforum der SPD e.V.
Wirtschaftsbeirat Bayern - Wirtschaftsbeirat der Union e.V.
Wirtschaftsrat der CDU e. V.Member organisations
None declared
-
Financial Data
Interests represented
Advances interests of their clients
Closed financial year
Jan 2021 - Dec 2021
Lobbying costs for closed financial year
300,000€
Major contributions in closed year
None declared
Clients for closed financial year
Clients list
Name Proposal Amount alexion pharma gmbh Revision of the general pharmaceuticals legislation; Revision of the EU OMP Regulation; Cross-Border Healthcare Directive; European Health Data Space; Clinical Trials Regulation (CTR); EU-HTA Regulation; Pharmaceutical Strategy for Europe 100,000€ - 199,999€ amazon europe core srl Digital Services Act, Digital Markets Act, Data Act, Implementation of Global Minimum Corporate Taxation, Secure Space-based Connectivity Regulation, General Product Safety Regulation, Artificial Intelligence Act 100,000€ - 199,999€ din e.v. Standardisation Strategy, Standardisation Regulation, Artificial Intelligence Act, Machinery Regulation, Construction Products Regulation, Data Act 50,000€ - 99,999€ Eli Lilly and Company Revision of General Pharmaceutical Legislation; Revision of Orphan Medicinal Products Legislation; Beating Cancer Plan; European Health Data Space; Health Technology Assessment Regulation; EMA Fees regulation; ‘Healthier Together’ Non-Communicable Diseases plan; Intellectual Property Rights and Incentives; Anti-Microbial Resistance; Industrial Strategy; Pharmaceutical Strategy; International Trade; International Health Regulations 50,000€ - 99,999€ Clients for current financial year
Clients list
Name din e.v. dahag rechtsservices ag amazon europe core srl alexion pharma gmbh Eli Lilly and Company Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Conference, virtual events, virtual and non-virtual meetings, report on annual activities
Other activities
None declared
- Meetings
Meetings
None declared
- Meetings